Literature DB >> 18978637

Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.

Georgina E Hale1, Claude L Hughes, Henry G Burger, David M Robertson, Ian S Fraser.   

Abstract

OBJECTIVE: The menopausal transition is characterized by irregular menstrual cycles and unpredictable hormone levels, including dramatic swings in estradiol (E2). An increasing number of studies have found variable high E2 and low luteal phase progesterone occur with progression of Stages of Reproductive Aging Workshop (STRAW)stage, but the cause remains unclear. To explore the causes of the erratic changes in E2, individual within-cycle secretion patterns of E2, progesterone, follicle-stimulating hormone, luteinizing hormone, inhibin A, and inhibin B were explored in detail.
DESIGN: Blood samples taken three times per week over 1 1/3 menstrual cycles from 77 women aged 21 to 55 classified as mid-reproductive age (STRAW stages 5 and 4; n = 21), late-reproductive age (STRAW stages 4 and 3; n = 16), early menopausal transition (STRAW stage 2; n = 17), and late menopausal transition (STRAW stage 1; n = 23) were analyzed.
RESULTS: Eleven of the 29 (37%) early and late menstrual transition ovulatory cycles exhibited a specific pattern of E2 secretion that was characterized by a second increase in E2 during the mid- and late luteal phases and that continued to a peak during the subsequent menstrual phase. This second rise and fall in E2 was typical in appearance of a normal follicular phase, except that it was superimposed on an existing ovulatory cycle(specifically during the luteal and menstrual phases). The pattern was therefore referred to as a luteal out-of-phase(LOOP) follicular event. In four of these LOOP cycles, a luteinizing hormone peak and ovulatory episode followed the second E2 peak early in the subsequent cycle. Compared with the typical ovulatory cycles, the cycles with LOOP events exhibited lower luteal phase progesterone, higher early cycle follicle-stimulating hormone, and lower early cycle inhibin B. They were also associated with abnormally short (<21 d) or long (>40 d) cycle length.
CONCLUSIONS: Many of the marked increases in ovulatory cycle E2 and cycle irregularities during the menopausal transition may be due to LOOP events and appear to be triggered by prolonged high follicular phase follicle-stimulating hormone levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18978637     DOI: 10.1097/GME.0b013e31817ee0c2

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  26 in total

Review 1.  Perimenopause: From Research to Practice.

Authors:  Nanette Santoro
Journal:  J Womens Health (Larchmt)       Date:  2015-12-10       Impact factor: 2.681

2.  Acute uterine bleeding unrelated to pregnancy: a Southern California Permanente Medical Group practice guideline.

Authors:  Malcolm G Munro
Journal:  Perm J       Date:  2013

Review 3.  Menstrual Cycle Hormone Changes Associated with Reproductive Aging and How They May Relate to Symptoms.

Authors:  Amanda Allshouse; Jelena Pavlovic; Nanette Santoro
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

4.  Subclinical impairment of ovarian reserve in systemic lupus erythematosus patients with normal menstruation not using alkylating therapy.

Authors:  Wenhong Ma; Zhongping Zhan; Xiaoyan Liang; Jianhui Chen; Xingfang Huang; Caiyun Liao
Journal:  J Womens Health (Larchmt)       Date:  2013-12       Impact factor: 2.681

5.  Trajectories of estradiol and follicle-stimulating hormone over the menopause transition and early markers of atherosclerosis after menopause.

Authors:  Samar R El Khoudary; Nanette Santoro; Hsiang-Yu Chen; Ping G Tepper; Maria M Brooks; Rebecca C Thurston; Imke Janssen; Sioban D Harlow; Emma Barinas-Mitchell; Faith Selzer; Carol A Derby; Elizabeth A Jackson; Daniel McConnell; Karen A Matthews
Journal:  Eur J Prev Cardiol       Date:  2015-09-18       Impact factor: 7.804

Review 6.  The menopause and aging, a comparative perspective.

Authors:  Caleb E Finch
Journal:  J Steroid Biochem Mol Biol       Date:  2013-04-10       Impact factor: 4.292

7.  Factors that influence entry into stages of the menopausal transition.

Authors:  Mary D Sammel; Ellen W Freeman; Ziyue Liu; Hui Lin; Wensheng Guo
Journal:  Menopause       Date:  2009 Nov-Dec       Impact factor: 2.953

8.  Hypoestrogenic "inactive phases" at the start of the menstrual cycle: changes with age and reproductive stage, and relationship to follicular depletion.

Authors:  Rebecca J Ferrell; Germán Rodríguez; Darryl Holman; Kathleen O'Connor; James W Wood; Maxine Weinstein
Journal:  Fertil Steril       Date:  2012-08-14       Impact factor: 7.329

Review 9.  Autoimmune diseases and reproductive aging.

Authors:  Riley Bove
Journal:  Clin Immunol       Date:  2013-02-28       Impact factor: 3.969

10.  Progesterone and bone: actions promoting bone health in women.

Authors:  Vanadin Seifert-Klauss; Jerilynn C Prior
Journal:  J Osteoporos       Date:  2010-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.